SARS-CoV-2 delta variant: a persistent threat to the effectiveness of vaccines - The Lancet

[unable to retrieve full-text content]

1. SARS-CoV-2 delta variant: a persistent threat to the effectiveness of vaccines  The Lancet
2. IFITM proteins are important replication cofactors for SARS-CoV-2, including Delta variant  News-Medical.net
3. Exposure to Harmless Coronaviruses Boosts COVID-19 Immunity  SciTechDaily
4. Hybrid immunity versus vaccine-induced immunity against SARS-CoV-2 in patients with autoimmune rheumatic diseases  The Lancet
5. Interferon beta versus the SARS-CoV-2 Delta variant  News-Medical.net
6. View Full coverage on Google News

https://news.google.com/__i/rss/rd/articles/CBMiU2h0dHBzOi8vd3d3LnRoZWxhbmNldC5jb20vam91cm5hbHMvbGFuaW5mL2FydGljbGUvUElJUzE0NzMtMzA5OSgyMSkwMDY5Ny02L2Z1bGx0ZXh00gEA?oc=5

2021-11-23 19:11:36Z
1067888340

Bagikan Berita Ini